Arca
Skip to content
Tools
Tools

Paroxysmal supraventricular tachycardia (PSVT)

Drug research and approvals for paroxysmal supraventricular tachycardia (PSVT): what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 22, 2026, 4 studies of paroxysmal supraventricular tachycardia (PSVT) are recruiting on ClinicalTrials.gov, and Health Canada has authorized 6 drug trials for it since 2013.

  • Recruiting worldwide: 4
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 0
  • EU medicines: 0

Recruiting now

Newest posted first, of 4 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

Newest first; search them all in Canada trials
Jun 11, 2026A randomized, double-blind trial of 12 mg versus 6 mg intravenous adenosine for the termination of paroxysmal supraventricular tachycardiaAdenosineDr. Seth DavisPending
Feb 8, 2024Multi-center, multi-national, open-label, efficacy and safety study of etripamil nasal spray in pediatric patients with paroxysmal supraventricular tachycardiaEtripamil (MSP-2017)Milestone PharmaceuticalsOngoing
Jan 19, 2021An open label extension study of etripamil nasal spray in patients with paroxysmal supraventricular tachycardiaEtripamil (MSP-2017)Milestone PharmaceuticalsClosed
Sep 19, 2019Multi-centre, multi-national, open label, safety study of etripamil nasal spray for patients with paroxysmal supraventricular tachycardiaEtripamil (MSP-2017)Milestone PharmaceuticalsClosed
Jul 11, 2018Multi-centre, open-label, safety study of etripamil nasal spray in spontaneous episodes of paroxysmal supraventricular tachycardiaEtripamil (MSP-2017)Milestone PharmaceuticalsClosed
Jun 6, 2018Multi-centre, randomized, double-blind, placebo-controlled, efficacy, and safety study of etripamil nasal spray for the termination of spontaneous episodes of…Etripamil (MSP-2017)Milestone PharmaceuticalsOngoing

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.